| name | Skyla |
| classification | Levonorgestrel-releasing intrauterine system (IUS) |
| pharmacokinetics | Skyla releases a low dose of levonorgestrel directly into the uterus. The hormone is absorbed locally, minimizing systemic exposure. Exact pharmacokinetic details, including specific plasma levels, are not commonly discussed in lay summaries. However, the low dose and local release route make systemic side effects less frequent than with oral contraceptives. |
| suggested dosage | Skyla is a single-use device inserted into the uterus by a healthcare professional. No dosage adjustment is necessary for a female patient. |
| indications | Skyla is a contraceptive device used to prevent pregnancy in women. It works by releasing hormones that prevent ovulation. |
| safety in pregnancy | Not for use in pregnant patients. Do not use if pregnancy is suspected. |
| safety in breastfeeding | Generally considered safe for breastfeeding women, as the hormone levels released are low and localized. |
| side effects | | 1 | Bleeding irregularities (e.g., spotting, prolonged bleeding, amenorrhea) | | 2 | Headache | | 3 | Breast tenderness | | 4 | Mood changes | | 5 | Weight changes (though not common) | | 6 | Pelvic pain | | 7 | Expulsion of device (rare) | | 8 | Infection (rare) | | 9 | Abdominal pain |
|
| contraindications | | 1 | Known or suspected pregnancy | | 2 | Uterine abnormalities (e.g., fibroids, polyps, significant scar tissue) | | 3 | Pelvic inflammatory disease (PID) | | 4 | History of ectopic pregnancy | | 5 | Suspected or known uterine or cervical cancer | | 6 | Active genital infection | | 7 | Allergy to any components of the device |
|
| interactions | Potential interactions with other medications, especially if taken systemically. Consult a doctor about other medications being taken. |
| warnings and precautions | | 1 | Regular check-ups with a healthcare provider are important. | | 2 | Device expulsion is possible, though rare. | | 3 | Changes in menstrual cycle may occur. | | 4 | Reduced milk production in breastfeeding mothers is rare but possible. |
|
| alternatives | |
| additional informations | Skyla is a long-acting reversible contraceptive (LARC). Consult a healthcare professional to determine suitability. |
| patient age | 25 |
| patient weight | 70 |
